30% off. Use code SUMMER30 at checkout for 30% off for 12 months on Pro and Premium subscriptions. Subscribe now

Mehalick David

Insider profile

Performance

Overall performance
0.8

Performance over holding periods
0.8
30 days 90 days 120 days
Average return -19% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
3 100% Buy
34 71% Buy
47 69% Buy
Mehalick David's trades of Coeptis Therapeutics Holdings Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-01-09 2024-01-08 B Purchase
67,137 +46.3%
420.26
US$2,404,987
67,137 +46.3% 420.26 US$2,404,987
2024-01-09 2024-01-08 B Purchase
82,663 -19.7%
466.30
US$3,047,387
82,663 -19.7% 466.30 US$3,047,387
2024-01-09 2024-01-05 B Purchase
91,564 +29.4%
284.43
US$1,596,771
91,564 +29.4% 284.43 US$1,596,771
2021-11-18 2021-11-16 S Sale
1,200,000
0.00
US$0
1,200,000 0.00 US$0